{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:48:51Z","timestamp":1789123731449,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2019A610341"],"award-info":[{"award-number":["2019A610341"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00109-022-02263-7","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:03:41Z","timestamp":1665187421000},"page":"1557-1568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["ATF3 in atherosclerosis: a controversial transcription factor"],"prefix":"10.1007","volume":"100","author":[{"given":"Bingyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5315-5346","authenticated-orcid":false,"given":"Jianqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"issue":"2","key":"2263_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.livres.2017.08.001","volume":"1","author":"K Jadhav","year":"2017","unstructured":"Jadhav K, Zhang Y (2017) Activating transcription factor 3 in immune response and metabolic regulation. Liver Res 1(2):96\u2013102","journal-title":"Liver Res"},{"issue":"1","key":"2263_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(01)00551-0","volume":"273","author":"T Hai","year":"2001","unstructured":"Hai T, Hartman MG (2001) The molecular biology and nomenclature of the activating transcription factor\/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273(1):1\u201311","journal-title":"Gene"},{"key":"2263_CR3","doi-asserted-by":"crossref","unstructured":"Guo Z et al (2018)\u00a0Insect Transcription Factors: A Landscape of Their Structures and Biological Functions in Drosophila and beyond. Int J Mol Sci\u00a019(11)","DOI":"10.3390\/ijms19113691"},{"key":"2263_CR4","doi-asserted-by":"crossref","unstructured":"Liang G et al (1996)\u00a0ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem\u00a0271(3):1695\u2013701","DOI":"10.1074\/jbc.271.3.1695"},{"key":"2263_CR5","volume":"2011","author":"A Baldi","year":"2011","unstructured":"Baldi A et al (2011) Tumor suppressors and cell-cycle proteins in lung cancer. Patholog Res Int 2011:605042","journal-title":"Patholog Res Int"},{"issue":"11","key":"2263_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00109-009-0520-x","volume":"87","author":"MR Thompson","year":"2009","unstructured":"Thompson MR, Xu D, Williams BR (2009) ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med (Berl) 87(11):1053\u20131060","journal-title":"J Mol Med (Berl)"},{"key":"2263_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnmol.2012.00007","volume":"5","author":"D Hunt","year":"2012","unstructured":"Hunt D, Raivich G, Anderson PN (2012) Activating transcription factor 3 and the nervous system. Front Mol Neurosci 5:7","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"2263_CR8","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1093\/nar\/30.11.2398","volume":"30","author":"Y Hashimoto","year":"2002","unstructured":"Hashimoto Y et al (2002) An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids Res 30(11):2398\u20132406","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2263_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s41419-020-03271-6","volume":"11","author":"Z Shi","year":"2020","unstructured":"Shi Z et al (2020) Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells. Cell Death Dis 11(12):1066","journal-title":"Cell Death Dis"},{"issue":"35","key":"2263_CR10","doi-asserted-by":"publisher","first-page":"32899","DOI":"10.1074\/jbc.M305456200","volume":"278","author":"J Wang","year":"2003","unstructured":"Wang J, Cao Y, Steiner DF (2003) Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element\/ATF site of the proglucagon gene promoter. J Biol Chem 278(35):32899\u201332904","journal-title":"J Biol Chem"},{"issue":"10","key":"2263_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026848","volume":"6","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y et al (2011) Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway. PLoS ONE 6(10):e26848","journal-title":"PLoS ONE"},{"issue":"5","key":"2263_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00395-018-0698-6","volume":"113","author":"H Zhou","year":"2018","unstructured":"Zhou H et al (2018) Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic Res Cardiol 113(5):37","journal-title":"Basic Res Cardiol"},{"key":"2263_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809457","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Ferroptosis signaling and regulators in atherosclerosis. Front Cell Dev Biol 9:809457","journal-title":"Front Cell Dev Biol"},{"key":"2263_CR14","doi-asserted-by":"crossref","unstructured":"Bezsonov EE, Sobenin IA, Orekhov AN (2021)\u00a0Immunopathology of atherosclerosis and related diseases: focus on molecular biology. Int J Mol Sci\u00a022(8)","DOI":"10.3390\/ijms22084080"},{"key":"2263_CR15","doi-asserted-by":"crossref","unstructured":"Gimbrone Jr. MA, Garc\u00eda-Carde\u00f1a G (2016)\u00a0Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res\u00a0118(4):620\u201336","DOI":"10.1161\/CIRCRESAHA.115.306301"},{"key":"2263_CR16","doi-asserted-by":"crossref","unstructured":"Mushenkova NV et al (2021)\u00a0Recognition of oxidized lipids by macrophages and its role in atherosclerosis development. Biomedicines\u00a09(8)","DOI":"10.3390\/biomedicines9080915"},{"issue":"13","key":"2263_CR17","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/MCB.24.13.5721-5732.2004","volume":"24","author":"MG Hartman","year":"2004","unstructured":"Hartman MG et al (2004) Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 24(13):5721\u20135732","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2263_CR18","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/cdd.2008.74","volume":"15","author":"L Turchi","year":"2008","unstructured":"Turchi L et al (2008) Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway. Cell Death Differ 15(9):1472\u20131480","journal-title":"Cell Death Differ"},{"issue":"2","key":"2263_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2013an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"issue":"41","key":"2263_CR20","doi-asserted-by":"publisher","first-page":"39025","DOI":"10.1074\/jbc.M202974200","volume":"277","author":"J Kawauchi","year":"2002","unstructured":"Kawauchi J et al (2002) Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 277(41):39025\u201339034","journal-title":"J Biol Chem"},{"key":"2263_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12864-016-2664-8","volume":"17","author":"J Zhao","year":"2016","unstructured":"Zhao J et al (2016) The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation. BMC Genomics 17:335","journal-title":"BMC Genomics"},{"key":"2263_CR22","doi-asserted-by":"crossref","unstructured":"Salnikova D et al (2021)\u00a0Mitochondrial dysfunction in vascular wall cells and its role in atherosclerosis. Int J Mol Sci\u00a022(16)","DOI":"10.3390\/ijms22168990"},{"issue":"2","key":"2263_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0021-9150(01)00639-6","volume":"161","author":"T Nawa","year":"2002","unstructured":"Nawa T et al (2002) Expression of transcriptional repressor ATF3\/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161(2):281\u2013291","journal-title":"Atherosclerosis"},{"issue":"9","key":"2263_CR24","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/ATVBAHA.113.301375","volume":"33","author":"HH Aung","year":"2013","unstructured":"Aung HH et al (2013) Induction of ATF3 gene network by triglyceride-rich lipoprotein lipolysis products increases vascular apoptosis and inflammation. Arterioscler Thromb Vasc Biol 33(9):2088\u20132096","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2263_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145523","volume":"10","author":"L Eiselein","year":"2015","unstructured":"Eiselein L et al (2015) TGRL lipolysis products induce stress protein ATF3 via the TGF-\u03b2 receptor pathway in human aortic endothelial cells. PLoS ONE 10(12):e0145523","journal-title":"PLoS ONE"},{"key":"2263_CR26","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2021e11612","volume":"55","author":"APS Mesquita","year":"2022","unstructured":"Mesquita APS et al (2022) Nitric oxide regulates adhesiveness, invasiveness, and migration of anoikis-resistant endothelial cells. Braz J Med Biol Res 55:e11612","journal-title":"Braz J Med Biol Res"},{"key":"2263_CR27","doi-asserted-by":"crossref","unstructured":"Ohukainen P et al (2015)\u00a0Activating transcription factor 3 (ATF3) and its downstream inflammatory targets are dysregulated in human calcific aortic valve disease. Atherosclerosis\u00a0241(1)","DOI":"10.1016\/j.atherosclerosis.2015.04.199"},{"issue":"6","key":"2263_CR28","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1182\/blood.V96.6.2140","volume":"96","author":"Y Cai","year":"2000","unstructured":"Cai Y et al (2000) Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96(6):2140\u20132148","journal-title":"Blood"},{"key":"2263_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2019.07.024","volume":"143","author":"T Nyunt","year":"2019","unstructured":"Nyunt T et al (2019) Mitochondrial oxidative stress-induced transcript variants of ATF3 mediate lipotoxic brain microvascular injury. Free Radic Biol Med 143:25\u201346","journal-title":"Free Radic Biol Med"},{"issue":"7090","key":"2263_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature04768","volume":"441","author":"M Gilchrist","year":"2006","unstructured":"Gilchrist M et al (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441(7090):173\u2013178","journal-title":"Nature"},{"issue":"4","key":"2263_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ibd\/izy296","volume":"25","author":"V Jaruvongvanich","year":"2019","unstructured":"Jaruvongvanich V, Poonsombudlert K, Ungprasert P (2019) Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis 25(4):672\u2013678","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"2263_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.mehy.2011.04.006","volume":"77","author":"RV Subramanyam","year":"2011","unstructured":"Subramanyam RV (2011) Occurrence of recurrent aphthous stomatitis only on lining mucosa and its relationship to smoking\u2013a possible hypothesis. Med Hypotheses 77(2):185\u2013187","journal-title":"Med Hypotheses"},{"issue":"4","key":"2263_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","volume":"15","author":"C Perricone","year":"2016","unstructured":"Perricone C et al (2016) Smoke and autoimmunity: the fire behind the disease. Autoimmun Rev 15(4):354\u2013374","journal-title":"Autoimmun Rev"},{"key":"2263_CR34","doi-asserted-by":"publisher","first-page":"39945","DOI":"10.1038\/srep39945","volume":"7","author":"JE Teasdale","year":"2017","unstructured":"Teasdale JE et al (2017) Cigarette smoke extract profoundly suppresses TNF\u03b1-mediated proinflammatory gene expression through upregulation of ATF3 in human coronary artery endothelial cells. Sci Rep 7:39945","journal-title":"Sci Rep"},{"issue":"2","key":"2263_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/dna.2021.0745","volume":"41","author":"J Qiu","year":"2022","unstructured":"Qiu J et al (2022) The role and research progress of inhibitor of differentiation 1 in atherosclerosis. DNA Cell Biol 41(2):71\u201379","journal-title":"DNA Cell Biol"},{"issue":"2","key":"2263_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2784","volume":"15","author":"D De Nardo","year":"2014","unstructured":"De Nardo D et al (2014) High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol 15(2):152\u2013160","journal-title":"Nat Immunol"},{"issue":"3","key":"2263_CR37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1128\/MCB.26.3.1087-1097.2006","volume":"26","author":"A Okamoto","year":"2006","unstructured":"Okamoto A, Iwamoto Y, Maru Y (2006) Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol 26(3):1087\u20131097","journal-title":"Mol Cell Biol"},{"key":"2263_CR38","doi-asserted-by":"publisher","first-page":"9762959","DOI":"10.1155\/2016\/9762959","volume":"2016","author":"G Krenning","year":"2016","unstructured":"Krenning G et al (2016) Endothelial plasticity: shifting phenotypes through force feedback. Stem Cells Int 2016:9762959","journal-title":"Stem Cells Int"},{"issue":"7","key":"2263_CR39","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","volume":"185","author":"RB Good","year":"2015","unstructured":"Good RB et al (2015) Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am J Pathol 185(7):1850\u20131858","journal-title":"Am J Pathol"},{"issue":"4","key":"2263_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cells4040631","volume":"4","author":"I Loeffler","year":"2015","unstructured":"Loeffler I, Wolf G (2015) Epithelial-to-mesenchymal transition in diabetic nephropathy: Fact or Fiction? Cells 4(4):631\u2013652","journal-title":"Cells"},{"issue":"1","key":"2263_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/21655979.2020.1860491","volume":"12","author":"XM Wang","year":"2021","unstructured":"Wang XM et al (2021) Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)\/SMAD signaling pathway. Bioengineered 12(1):117\u2013126","journal-title":"Bioengineered"},{"issue":"8","key":"2263_CR42","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41419-020-02818-x","volume":"11","author":"L Hong","year":"2020","unstructured":"Hong L et al (2020) Semaphorin 7A promotes endothelial to mesenchymal transition through ATF3 mediated TGF-beta2\/Smad signaling. Cell Death Dis 11(8):695","journal-title":"Cell Death Dis"},{"issue":"8 Pt 2","key":"2263_CR43","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/clinchem\/44.8.1809","volume":"44","author":"RO Cannon 3rd","year":"1998","unstructured":"Cannon RO 3rd (1998) Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44(8 Pt 2):1809\u20131819","journal-title":"Clin Chem"},{"key":"2263_CR44","first-page":"8514056","volume":"2016","author":"KR Paudel","year":"2016","unstructured":"Paudel KR, Panth N, Kim DW (2016) Circulating endothelial microparticles: a key hallmark of atherosclerosis progression. Scientifica (Cairo) 2016:8514056","journal-title":"Scientifica (Cairo)"},{"issue":"5","key":"2263_CR45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1124\/mol.65.5.1130","volume":"65","author":"HH Chen","year":"2004","unstructured":"Chen HH, Wang DL (2004) Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. Mol Pharmacol 65(5):1130\u20131140","journal-title":"Mol Pharmacol"},{"key":"2263_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yjmcc.2016.02.001","volume":"92","author":"Z-B Zhang","year":"2016","unstructured":"Zhang Z-B et al (2016) Activating transcription factor 3 SUMOylation is involved in angiotensin II-induced endothelial cell inflammation and dysfunction. J Mol Cell Cardiol 92:149\u2013157","journal-title":"J Mol Cell Cardiol"},{"key":"2263_CR47","doi-asserted-by":"crossref","unstructured":"Du C et al (2021)\u00a0The function of SUMOylation and its critical roles in cardiovascular diseases and potential clinical implications. Int J Mol Sci\u00a022(19)","DOI":"10.3390\/ijms221910618"},{"issue":"4","key":"2263_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213331","volume":"14","author":"N Rawlings","year":"2019","unstructured":"Rawlings N et al (2019) Protective role of the deSUMOylating enzyme SENP3 in myocardial ischemia-reperfusion injury. PLoS ONE 14(4):e0213331","journal-title":"PLoS ONE"},{"issue":"5","key":"2263_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.metabol.2016.01.007","volume":"65","author":"E Chang","year":"2016","unstructured":"Chang E, Abe JI (2016) Kinase-SUMO networks in diabetes-mediated cardiovascular disease. Metabolism 65(5):623\u2013633","journal-title":"Metabolism"},{"issue":"3","key":"2263_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121823","volume":"10","author":"WP Zhou","year":"2015","unstructured":"Zhou WP et al (2015) RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice. PLoS ONE 10(3):e0121823","journal-title":"PLoS ONE"},{"issue":"1","key":"2263_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13577-020-00432-9","volume":"34","author":"W Qin","year":"2021","unstructured":"Qin W et al (2021) Activating transcription factor 3 is a potential target and a new biomarker for the prognosis of atherosclerosis. Hum Cell 34(1):49\u201359","journal-title":"Hum Cell"},{"issue":"6","key":"2263_CR52","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.308685","volume":"119","author":"SA Didichenko","year":"2016","unstructured":"Didichenko SA et al (2016) Enhanced HDL functionality in small HDL species produced upon remodeling of HDL by reconstituted HDL, CSL112: effects on cholesterol efflux, anti-inflammatory and antioxidative activity. Circ Res 119(6):751\u2013763","journal-title":"Circ Res"},{"issue":"4","key":"2263_CR53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1084\/jem.20111202","volume":"209","author":"ES Gold","year":"2012","unstructured":"Gold ES et al (2012) ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med 209(4):807\u2013817","journal-title":"J Exp Med"},{"issue":"5","key":"2263_CR54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nm.4315","volume":"23","author":"M Nus","year":"2017","unstructured":"Nus M et al (2017) Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet. Nat Med 23(5):601\u2013610","journal-title":"Nat Med"},{"issue":"3","key":"2263_CR55","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2016-209683","volume":"76","author":"CK Smith","year":"2017","unstructured":"Smith CK et al (2017) Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity. Ann Rheum Dis 76(3):602\u2013611","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"2263_CR56","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.116.022668","volume":"134","author":"M Cl\u00e9ment","year":"2016","unstructured":"Cl\u00e9ment M et al (2016) Necrotic cell sensor Clec4e promotes a proatherogenic macrophage phenotype through activation of the unfolded protein response. Circulation 134(14):1039\u20131051","journal-title":"Circulation"},{"issue":"1","key":"2263_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s42255-020-00331-1","volume":"3","author":"Y Xu","year":"2021","unstructured":"Xu Y et al (2021) Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat Metab 3(1):59\u201374","journal-title":"Nat Metab"},{"issue":"1\u20132","key":"2263_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1515\/labmed-2017-0138","volume":"42","author":"SR Hosseini-Fard","year":"2018","unstructured":"Hosseini-Fard SR et al (2018) ATF3 and EGR2 gene expression levels in sdLDL-treated macrophages of patients with coronary artery stenosis. LaboratoriumsMedizin 42(1\u20132):23\u201329","journal-title":"LaboratoriumsMedizin"},{"issue":"11","key":"2263_CR59","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1161\/ATVBAHA.121.316600","volume":"41","author":"C Yap","year":"2021","unstructured":"Yap C et al (2021) Six shades of vascular smooth muscle cells illuminated by KLF4 (Kr\u00fcppel-Like Factor 4). Arterioscler Thromb Vasc Biol 41(11):2693\u20132707","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2263_CR60","doi-asserted-by":"crossref","unstructured":"Casili G et al (2020)\u00a0The inhibition of prolyl oligopeptidase as new target to counteract chronic venous insufficiency: findings in a mouse model. Biomedicines\u00a08(12)","DOI":"10.3390\/biomedicines8120604"},{"key":"2263_CR61","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.omtn.2021.01.024","volume":"23","author":"X Yang","year":"2021","unstructured":"Yang X et al (2021) Targeting the epigenome in in-stent restenosis: from mechanisms to therapy. Mol Ther Nucleic Acids 23:1136\u20131160","journal-title":"Mol Ther Nucleic Acids"},{"key":"2263_CR62","doi-asserted-by":"crossref","unstructured":"Wang Y et al (2021)\u00a0Dynamic changes in chromatin accessibility are associated with the atherogenic transitioning of vascular smooth muscle cells. Cardiovasc Res","DOI":"10.1093\/cvr\/cvab347"},{"issue":"5","key":"2263_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001309","volume":"3","author":"L Huang","year":"2014","unstructured":"Huang L et al (2014) Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation. J Am Heart Assoc 3(5):e001309","journal-title":"J Am Heart Assoc"},{"key":"2263_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2020.11.009","volume":"315","author":"WJ Chen","year":"2020","unstructured":"Chen WJ et al (2020) CREB\/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia. Atherosclerosis 315:43\u201354","journal-title":"Atherosclerosis"},{"key":"2263_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.540591","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X et al (2020) Mechanical stretch induces smooth muscle cell dysfunction by regulating ACE2 via P38\/ATF3 and post-transcriptional regulation by miR-421. Front Physiol 11:540591","journal-title":"Front Physiol"},{"key":"2263_CR66","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.omtn.2020.09.030","volume":"22","author":"N Choe","year":"2020","unstructured":"Choe N et al (2020) miR-27a-3p targets ATF3 to reduce calcium deposition in vascular smooth muscle cells. Mol Ther Nucleic Acids 22:627\u2013639","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"2263_CR67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000330175","volume":"34","author":"NX Chen","year":"2011","unstructured":"Chen NX et al (2011) Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol 34(3):211\u2013219","journal-title":"Am J Nephrol"},{"issue":"5","key":"2263_CR68","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/ndt\/gfv321","volume":"31","author":"E Hecht","year":"2016","unstructured":"Hecht E et al (2016) The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications. Nephrol Dial Transplant 31(5):789\u2013797","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2263_CR69","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/iub.416","volume":"63","author":"D Lv","year":"2011","unstructured":"Lv D et al (2011) Activating transcription factor 3 regulates survivability and migration of vascular smooth muscle cells. IUBMB Life 63(1):62\u201369","journal-title":"IUBMB Life"},{"issue":"10","key":"2263_CR70","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13(10):709\u2013721","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2263_CR71","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.2337\/db05-1507","volume":"55","author":"HB Kim","year":"2006","unstructured":"Kim HB et al (2006) NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes. Diabetes 55(5):1342\u20131352","journal-title":"Diabetes"},{"issue":"1","key":"2263_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbrc.2010.08.011","volume":"400","author":"HJ Park","year":"2010","unstructured":"Park HJ et al (2010) ATF3 negatively regulates adiponectin receptor 1 expression. Biochem Biophys Res Commun 400(1):72\u201377","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2263_CR73","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1111\/j.1742-4658.2010.07646.x","volume":"277","author":"IU Koh","year":"2010","unstructured":"Koh IU et al (2010) AdipoR2 is transcriptionally regulated by ER stress-inducible ATF3 in HepG2 human hepatocyte cells. Febs j 277(10):2304\u20132317","journal-title":"Febs j"},{"issue":"3","key":"2263_CR74","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1210\/en.2012-1515","volume":"154","author":"SH Tsai","year":"2013","unstructured":"Tsai SH et al (2013) Knockdown of RyR3 enhances adiponectin expression through an atf3-dependent pathway. Endocrinology 154(3):1117\u20131129","journal-title":"Endocrinology"},{"issue":"3","key":"2263_CR75","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbrc.2012.12.154","volume":"431","author":"MK Jang","year":"2013","unstructured":"Jang MK, Son Y, Jung MH (2013) ATF3 plays a role in adipocyte hypoxia-mediated mitochondria dysfunction in obesity. Biochem Biophys Res Commun 431(3):421\u2013427","journal-title":"Biochem Biophys Res Commun"},{"key":"2263_CR76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42003-019-0624-y","volume":"2","author":"CF Cheng","year":"2019","unstructured":"Cheng CF et al (2019) Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3. Commun Biol 2:389","journal-title":"Commun Biol"},{"issue":"1","key":"2263_CR77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbrc.2012.03.104","volume":"421","author":"MK Jang","year":"2012","unstructured":"Jang MK et al (2012) ATF3 inhibits adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 421(1):38\u201343","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2263_CR78","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.4049\/jimmunol.1500204","volume":"195","author":"LI Labzin","year":"2015","unstructured":"Labzin LI et al (2015) ATF3 Is a key regulator of macrophage IFN responses. J Immunol 195(9):4446\u20134455","journal-title":"J Immunol"},{"issue":"11","key":"2263_CR79","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.5551\/jat.28415","volume":"22","author":"H Luo","year":"2015","unstructured":"Luo H et al (2015) ATF3 inhibits Tenascin-C-induced foam cell formation in LPS-stimulated THP-1 macrophages by suppressing TLR-4. J Atheroscler Thromb 22(11):1214\u20131223","journal-title":"J Atheroscler Thromb"},{"key":"2263_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/716481","volume":"2013","author":"PF Lai","year":"2013","unstructured":"Lai PF et al (2013) ATF3 Protects against LPS-induced inflammation in mice via inhibiting HMGB1 expression. Evid Based Complement Alternat Med 2013:716481","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"2263_CR81","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbalip.2018.04.005","volume":"1863","author":"Y Wang","year":"2018","unstructured":"Wang Y, Ding WX, Li T (2018) Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. Biochim Biophys Acta Mol Cell Biol Lipids 1863(7):726\u2013733","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"11","key":"2263_CR82","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.2337\/db21-0181","volume":"70","author":"Y Xu","year":"2021","unstructured":"Xu Y et al (2021) Hepatocytic activating transcription factor 3 protects against steatohepatitis via hepatocyte nuclear factor 4\u03b1. Diabetes 70(11):2506\u20132517","journal-title":"Diabetes"},{"issue":"9","key":"2263_CR83","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41419-018-0894-1","volume":"9","author":"Q Zhu","year":"2018","unstructured":"Zhu Q et al (2018) Loss of ATF3 exacerbates liver damage through the activation of mTOR\/p70S6K\/ HIF-1\u03b1 signaling pathway in liver inflammatory injury. Cell Death Dis 9(9):910","journal-title":"Cell Death Dis"},{"issue":"1","key":"2263_CR84","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/ajt.12954","volume":"15","author":"J Rao","year":"2015","unstructured":"Rao J et al (2015) ATF3-mediated NRF2\/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia\/reperfusion injury. Am J Transplant 15(1):76\u201387","journal-title":"Am J Transplant"},{"key":"2263_CR85","first-page":"4235126","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Silencing ATF3 might delay TBHP-induced intervertebral disc degeneration by repressing NPC ferroptosis, apoptosis, and ECM degradation. Oxid Med Cell Longev 2022:4235126","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"2263_CR86","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1681\/ASN.2012050438","volume":"23","author":"YF Lan","year":"2012","unstructured":"Lan YF et al (2012) MicroRNA-494 reduces ATF3 expression and promotes AKI. J Am Soc Nephrol 23(12):2012\u20132023","journal-title":"J Am Soc Nephrol"},{"key":"2263_CR87","first-page":"3137329","volume":"2022","author":"YP Liu","year":"2022","unstructured":"Liu YP et al (2022) Role of posttranslational modifications of proteins in cardiovascular disease. Oxid Med Cell Longev 2022:3137329","journal-title":"Oxid Med Cell Longev"},{"key":"2263_CR88","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2013.10.008","volume":"71","author":"Z Cui","year":"2014","unstructured":"Cui Z et al (2014) Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond. J Mol Cell Cardiol 71:32\u201342","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"2263_CR89","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1681\/ASN.2009070690","volume":"21","author":"HF Li","year":"2010","unstructured":"Li HF et al (2010) ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol 21(6):1003\u20131013","journal-title":"J Am Soc Nephrol"},{"key":"2263_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101518","volume":"62","author":"N Willemsen","year":"2022","unstructured":"Willemsen N et al (2022) Proteasome dysfunction disrupts adipogenesis and induces inflammation via ATF3. Mol Metab 62:101518","journal-title":"Mol Metab"},{"key":"2263_CR91","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/1471-2407-10-668","volume":"10","author":"C Hackl","year":"2010","unstructured":"Hackl C et al (2010) Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer 10:668","journal-title":"BMC Cancer"},{"issue":"18","key":"2263_CR92","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.18632\/oncotarget.2322","volume":"5","author":"JJ Xie","year":"2014","unstructured":"Xie JJ et al (2014) ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma. Oncotarget 5(18):8569\u20138582","journal-title":"Oncotarget"},{"issue":"12","key":"2263_CR93","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1158\/0008-5472.CAN-12-3879","volume":"73","author":"X Yuan","year":"2013","unstructured":"Yuan X et al (2013) ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. Cancer Res 73(12):3625\u20133637","journal-title":"Cancer Res"},{"issue":"13","key":"2263_CR94","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.1074\/jbc.M113.503755","volume":"289","author":"S Wei","year":"2014","unstructured":"Wei S et al (2014) The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins. J Biol Chem 289(13):8947\u20138959","journal-title":"J Biol Chem"},{"issue":"38","key":"2263_CR95","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1038\/onc.2014.426","volume":"34","author":"Z Wang","year":"2015","unstructured":"Wang Z et al (2015) Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model. Oncogene 34(38):4975\u20134984","journal-title":"Oncogene"},{"issue":"9","key":"2263_CR96","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neo.2016.07.004","volume":"18","author":"J Bar","year":"2016","unstructured":"Bar J et al (2016) Induction of activating transcription factor 3 is associated with cisplatin responsiveness in non-small cell lung carcinoma cells. Neoplasia 18(9):525\u2013535","journal-title":"Neoplasia"},{"issue":"2","key":"2263_CR97","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1158\/1535-7163.233.4.2","volume":"4","author":"C Yan","year":"2005","unstructured":"Yan C et al (2005) Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther 4(2):233\u2013241","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"2263_CR98","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1158\/1535-7163.MCT-15-0890","volume":"15","author":"D Sooraj","year":"2016","unstructured":"Sooraj D et al (2016) Activating transcription factor 3 expression as a marker of response to the histone deacetylase inhibitor pracinostat. Mol Cancer Ther 15(7):1726\u20131739","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-022-02263-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-022-02263-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-022-02263-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T22:04:34Z","timestamp":1666735474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-022-02263-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":98,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1007\/s00109-022-02263-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review is not applied.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and data availability"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}